Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipton, R.B.
Right arrow Articles by Harrison, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipton, R.B.
Right arrow Articles by Harrison, W.
Related Collections
Right arrow Screening in epidemiology
Right arrow All Headache
Right arrow Low pressure syndrome

Neurology 2003;61:375-382
© 2003 American Academy of Neurology

A self-administered screener for migraine in primary care

The ID MigraineTM validation study

R.B. Lipton, MD, D. Dodick, MD, R. Sadovsky, MD, K. Kolodner, PhD, J. Endicott, PhD, J. Hettiarachchi, MD and W. Harrison, MD

From the Departments of Neurology, Psychiatry, Epidemiology, and Population Health (Dr. Lipton), Albert Einstein College of Medicine, New York, NY; IMR, a Division of AdvancePCS (Dr. Kolodner), Hunt Valley, MD; Department of Neurology (Dr. Dodick), Mayo Clinic, Scottsdale, AZ; Department Family Practice/SUNY Downstate Medical Center at Brooklyn (Dr. Sadovsky), NY; New York State Psychiatric Institute (Dr. Endicott), New York; and Pfizer Inc. (Drs. Hettiarachchi and Harrison), New York, NY.

Address correspondence and reprint requests to Dr. Richard B. Lipton, Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Rousso Building, Room 332, Bronx, NY 10461; e-mail: rlipton{at}aecom.yu.edu

Background: Migraine is a highly prevalent and disabling illness that remains substantially undiagnosed in primary care. Because of the potential value of a screening tool, the current study was designed to establish the validity and reliability of a brief, self-administered migraine screener in patients with headache complaints in the primary care setting.

Methods: A total of 563 patients presenting for routine primary care appointments and reporting headaches in the past 3 months completed a self-administered migraine screener. All patients were then referred for an independent diagnostic evaluation by a headache expert, of whom 451 (80%) completed a full evaluation. Migraine diagnosis was assigned based on International Headache Society criteria after completing a semi-structured diagnostic interview.

Results: Of nine diagnostic screening questions, a three-item subset of disability, nausea, and sensitivity to light provided optimum performance, with a sensitivity of 0.81 (95% CI, 0.77 to 0.85), a specificity of 0.75 (95% CI, 0.64 to 0.84), and positive predictive value of 0.93 (95% CI, 89.9 to 95.8). Test-retest reliability was good, with a kappa of 0.68 (95% CI, 0.54 to 0.82). The sensitivity and specificity of the three-item migraine screener was similar regardless of sex, age, presence of other comorbid headaches, or previous diagnostic status.

Conclusions: The three-item ID MigraineTM migraine screener was found to be a valid and reliable screening instrument for migraine headaches. Its ease of use and operating characteristics suggest that it could significantly improve migraine recognition in primary care.




This article has been cited by other articles:


Home page
NeurologyHome page
A. Siva, M. Zarifoglu, M. Ertas, S. Saip, H. N. Karli, B. Baykan, A. Keskinaslan, and M. Senocak
Validity of the ID-Migraine screener in the workplace
Neurology, April 15, 2008; 70(16): 1337 - 1345.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
L. L. Mueller
Diagnosing and Managing Migraine Headache
J Am Osteopath Assoc, November 1, 2007; 107(suppl_6): ES10 - ES16.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
T. Tucker
A Practical Approach to Headache Treatment
Journal of Pharmacy Practice, April 1, 2007; 20(2): 123 - 136.
[Abstract] [PDF]


Home page
JAMAHome page
M. E. Detsky, D. R. McDonald, M. O. Baerlocher, G. A. Tomlinson, D. C. McCrory, and C. M. Booth
Does this patient with headache have a migraine or need neuroimaging?
JAMA, September 13, 2006; 296(10): 1274 - 1283.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Paemeleire, A. Bahra, S. Evers, M. S. Matharu, and P. J. Goadsby
Medication-overuse headache in patients with cluster headache.
Neurology, July 11, 2006; 67(1): 109 - 113.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
K K Gahir and A J Larner
Primary headache disorder in the emergency department: perspective from a general neurology outpatient clinic
Emerg. Med. J., February 1, 2006; 23(2): 135 - 136.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
A. W Chessman
A 3 item screening instrument had moderate sensitivity and specificity for detecting migraine headaches
Evid. Based Med., March 1, 2004; 9(2): 56 - 56.
[Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
Other articles noted: 25 Jul 03 to 7 Nov 03
Evid. Based Nurs., January 1, 2004; 7(1): e1 - 1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.